Sonnet BioTherapeutics Holdings, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
SONN on Nasdaq
Location
100 Overlook Center, Suite 102, Princeton, NJ

There are no Buy or Sell transactions made by insiders since 12/6/2024

Sonnet BioTherapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Markey 10%+ Owner $131K Aug 7, 2023
Pankaj Mohan Chairman, President and CEO, Director $10.8K Dec 11, 2023
John Harry Cross III Chief Financial Officer $1.11K Dec 11, 2023
Susan Dexter Director $0 Dec 2, 2025
Albert D. Dyrness Director $0 Dec 2, 2025
Nailesh Bhatt Director $0 Dec 2, 2025
Raghu Rao Chief Executive Officer, Director $0 Dec 2, 2025
Lori McNeill Director $0 Dec 2, 2025
Stephen J. Mcandrew Chief Business Officer $0 Dec 2, 2025
Donald Griffith Chief Financial Officer, Director $0 Dec 2, 2025
Richard T. Kenney Chief Medical Officer $0 Dec 2, 2025
John K. Cini Director $0 Dec 2, 2025

Recent Insider Transactions by Companies or Individuals for Sonnet BioTherapeutics Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.